Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan
First minimally invasive device to treat people in Japan with common leaky heart valve for whom surgery is too risky
More than 50,000 patients worldwide have been treated with the MitraClip therapy
ABBOTT PARK, Ill., Nov. 6, 2017 -- (Healthcare Sales... Devices, Interventional, Cardiology, Regulatory Abbott, MitraClip, Mitral Valve Repair, mitral regurgitation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Gastroschisis Repair | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Japan Health | Pharmaceuticals